These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27457354)

  • 1. Platelets contribute to growth and metastasis in hepatocellular carcinoma.
    Bihari C; Rastogi A; Shasthry SM; Bajpai M; Bhadoria AS; Rajesh S; Mukund A; Kumar A; Sarin SK
    APMIS; 2016 Sep; 124(9):776-86. PubMed ID: 27457354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of pre-transplant platelet to lymphocyte ratio for hepatocellular carcinoma recurrence after liver transplantation.
    Xia W; Ke Q; Wang Y; Wang W; Zhang M; Shen Y; Wu J; Xu X; Zheng S
    World J Surg Oncol; 2015 Feb; 13():60. PubMed ID: 25885777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma.
    Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
    J Surg Res; 2015 Sep; 198(1):73-9. PubMed ID: 26022997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological and prognostic significance of platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma.
    Song W; Wang K; Zhong FP; Fan YW; Peng L; Zou SB
    Oncotarget; 2016 Dec; 7(49):81830-81838. PubMed ID: 27833084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization.
    Fan W; Zhang Y; Wang Y; Yao X; Yang J; Li J
    PLoS One; 2015; 10(3):e0119312. PubMed ID: 25742141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between hepatocellular carcinoma and hepatitis B virus infection in patients with and without cirrhosis.
    Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
    Ann Surg Oncol; 2014 Feb; 21(2):458-65. PubMed ID: 24132624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma.
    Li X; Chen ZH; Xing YF; Wang TT; Wu DH; Wen JY; Chen J; Lin Q; Dong M; Wei L; Ruan DY; Lin ZX; Wu XY; Ma XK
    Tumour Biol; 2015 Apr; 36(4):2263-9. PubMed ID: 25409616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet Distribution Width in Hepatocellular Carcinoma.
    Guo F; Zhu X; Qin X
    Med Sci Monit; 2018 Apr; 24():2518-2523. PubMed ID: 29689031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment platelet count early predicts extrahepatic metastasis of human hepatoma.
    Lee CH; Lin YJ; Lin CC; Yen CL; Shen CH; Chang CJ; Hsieh SY
    Liver Int; 2015 Oct; 35(10):2327-36. PubMed ID: 25752212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinoma.
    Alkozai EM; Porte RJ; Adelmeijer J; Zanetto A; Simioni P; Senzolo M; Lisman T
    Platelets; 2015; 26(6):577-82. PubMed ID: 25275728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. King's score as a novel prognostic model for patients with hepatitis B-associated hepatocellular carcinoma.
    Pang Q; Bi JB; Xu XS; Liu SS; Zhang JY; Zhou YY; Qu K; Liu C
    Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1337-46. PubMed ID: 26275082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PROX1 promotes hepatocellular carcinoma metastasis by way of up-regulating hypoxia-inducible factor 1α expression and protein stability.
    Liu Y; Zhang JB; Qin Y; Wang W; Wei L; Teng Y; Guo L; Zhang B; Lin Z; Liu J; Ren ZG; Ye QH; Xie Y
    Hepatology; 2013 Aug; 58(2):692-705. PubMed ID: 23505027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver stiffness measurement in patients with cirrhosis and hepatocellular carcinoma: a case-control study.
    Nahon P; Kettaneh A; Lemoine M; Seror O; Barget N; Trinchet JC; Beaugrand M; Ganne-Carrié N
    Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):214-9. PubMed ID: 19212210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum vascular endothelial growth factor per platelet count in hepatocellular carcinoma: correlations with clinical parameters and survival.
    Kim SJ; Choi IK; Park KH; Yoon SY; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
    Jpn J Clin Oncol; 2004 Apr; 34(4):184-90. PubMed ID: 15121753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-to-lymphocyte ratio in the setting of liver transplantation for hepatocellular cancer: A systematic review and meta-analysis.
    Lai Q; Melandro F; Larghi Laureiro Z; Giovanardi F; Ginanni Corradini S; Ferri F; Hassan R; Rossi M; Mennini G
    World J Gastroenterol; 2018 Apr; 24(15):1658-1665. PubMed ID: 29686473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between platelet to lymphocyte ratio (PLR) and overall survival (OS) of hepatocellular carcinoma (HCC): A meta-analysis.
    Hu DH; Yu SM
    Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):30-32. PubMed ID: 28886327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of the serum brain-derived neurotrophic factor and platelets in hepatocellular carcinoma.
    Yang ZF; Ho DW; Lau CK; Tam KH; Lam CT; Yu WC; Poon RT; Fan ST
    Oncol Rep; 2006 Dec; 16(6):1237-43. PubMed ID: 17089044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recurrence and metastasis of hepatocellular carcinoma after liver transplantation: single center experiences].
    Zheng SS; Chen J; Wang WL; Zhang M; Shen Y; Wu J; Xu X; Yan S
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1609-13. PubMed ID: 19094751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion.
    Ng L; Tung-Ping Poon R; Yau S; Chow A; Lam C; Li HS; Chung-Cheung Yau T; Law WL; Pang R
    Hepatology; 2013 Aug; 58(2):667-79. PubMed ID: 23504997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant-induced pseudothrombocytopenia occurring after transcatheter arterial embolization for hepatocellular carcinoma.
    Yoshikawa T; Nakanishi K; Maruta T; Takenaka D; Hirota S; Matsumoto S; Saigo K; Ohno Y; Fujii M; Sugimura K
    Jpn J Clin Oncol; 2006 Aug; 36(8):527-31. PubMed ID: 16793782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.